首页|期刊导航|中华医学杂志（英文版）|Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors

Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors

Qing-Yu Xu Li Yu

中华医学杂志（英文版）2020，Vol.133Issue(6)：699-715,17.

中华医学杂志（英文版）2020，Vol.133Issue(6)：699-715,17.DOI:10.1097/CM9.0000000000000685

Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors

Qing-Yu Xu ¹Li Yu²

作者信息

1. Department of Hematology-Oncology, International Cancer Center, Shenzhen University General Hospital, Shenzhen University Health Science Center, Shenzhen, Guangdong 518000, China
2. Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim 68169, Germany
折叠

摘要

关键词

Acute myeloid leukemia/Decitabine/5-azacytidine/Histone deacetylase inhibitors/Intensive chemotherapy

Key words

Acute myeloid leukemia/Decitabine/5-azacytidine/Histone deacetylase inhibitors/Intensive chemotherapy

引用本文复制引用

Qing-Yu Xu,Li Yu..Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors[J].中华医学杂志（英文版）,2020,133(6):699-715,17.

基金项目

This work was supported by grants from the National Natural Science Foundation of China (No.81670162,No.81970151,and No.81470010). （No.81670162,No.81970151,and No.81470010）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINESCI

ISSN：0366-6999

访问量0

下载量0

段落导航